Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Oligodendroglioma × Diphtheria-Tetanus Vaccine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Xanthomatosis, Cerebrotendinous 1 Oligodendroglioma 1 Melanoma 1 Medulloblastoma 1 Influenza, Human 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 24 Filgrastim 8 Irinotecan 7 Carboplatin 7 Flucytosine 6 Carmustine 6 O(6)-benzylguanine 5 sargramostim 4 Surgical Procedures, Operative 4 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4 vocimagene amiretrorepvec 3 Lenalidomide 3 Imatinib Mesylate 3 Genetic Therapy 3 Erlotinib Hydrochloride 3 Cyclophosphamide 3 Bortezomib 3 temsirolimus 2 lonafarnib 2 cediranib 2 Vorinostat 2 Vinblastine 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiosurgery 2 Radiation 2 Peripheral Blood Stem Cell Transplantation 2 Iodine-125 2 Immunohistochemistry 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06254326 2026-03-09

ADAGiO

University of Florida

Phase 1 Active not recruiting

Brain Neoplasms, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡